AR049176A1 - Vacuna que comprende un pestivirus atenuado - Google Patents
Vacuna que comprende un pestivirus atenuadoInfo
- Publication number
- AR049176A1 AR049176A1 ARP050102032A ARP050102032A AR049176A1 AR 049176 A1 AR049176 A1 AR 049176A1 AR P050102032 A ARP050102032 A AR P050102032A AR P050102032 A ARP050102032 A AR P050102032A AR 049176 A1 AR049176 A1 AR 049176A1
- Authority
- AR
- Argentina
- Prior art keywords
- vdvb
- pestiviruses
- vaccine
- attenuated
- pestivirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a pestivirus atenuados, en particular a VDVB atenuado, en donde al menos una mutacion está en la secuencia codificadora de la glicoproteína Erns y al menos otra mutacion está en la secuencia codificadora de Npro, que preferiblemente conduce a una inactivacion combinada de la actividad de Rnasa que reside en la glicoproteína Erns, además de la inactivacion de la actividad inmunomoduladora (en hipotesis) que reside en Npro. La presente también se refiere a métodos para atenuar pestivirus tal como VDVB, ácidos nucleicos que codifican dichos pestivirus, en particular VDVB, a composiciones y a vacunas que comprenden los pestivirus atenuados, en particular el VDVB de la presente. Reivindicacion 31: Uso de un virus de acuerdo con una cualquiera de las reivindicaciones 1 a 26 en la fabricacion de una vacuna para la profilaxis y el tratamiento de una infeccion por pestivirus
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004025452A DE102004025452A1 (de) | 2004-05-19 | 2004-05-19 | Vakzine enthaltend BVDV |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049176A1 true AR049176A1 (es) | 2006-07-05 |
Family
ID=34967522
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102032A Pending AR049176A1 (es) | 2004-05-19 | 2005-05-18 | Vacuna que comprende un pestivirus atenuado |
ARP160101219A AR104448A2 (es) | 2004-05-19 | 2016-04-28 | Una composición que comprende un pestivirus atenuado de dvb |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160101219A AR104448A2 (es) | 2004-05-19 | 2016-04-28 | Una composición que comprende un pestivirus atenuado de dvb |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1751276B9 (es) |
JP (2) | JP5006782B2 (es) |
KR (1) | KR100908798B1 (es) |
CN (2) | CN103352030B (es) |
AR (2) | AR049176A1 (es) |
AT (1) | ATE420949T1 (es) |
AU (1) | AU2005243488B2 (es) |
BR (1) | BRPI0510396B1 (es) |
CA (1) | CA2561719C (es) |
CY (4) | CY1109036T1 (es) |
DE (2) | DE102004025452A1 (es) |
DK (1) | DK1751276T5 (es) |
ES (1) | ES2321210T3 (es) |
HU (2) | HUS1500033I1 (es) |
LU (3) | LU92749I2 (es) |
ME (1) | ME01119B (es) |
MX (1) | MXPA06013298A (es) |
NL (3) | NL300745I1 (es) |
NZ (1) | NZ552088A (es) |
PL (1) | PL1751276T3 (es) |
PT (1) | PT1751276E (es) |
RS (1) | RS50753B9 (es) |
SI (1) | SI1751276T1 (es) |
UY (1) | UY28905A1 (es) |
WO (1) | WO2005111201A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
UY29915A1 (es) * | 2005-11-15 | 2007-06-29 | Boehringer Ingelheim Vetmed | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina |
US8071108B2 (en) | 2006-09-22 | 2011-12-06 | Intervet International B.V. | Pestivirus mutant for use in a vaccine |
AR069087A1 (es) | 2007-10-29 | 2009-12-30 | Boehringer Ingelheim Vetmed | Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma |
UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
EP2362780B1 (en) | 2008-10-31 | 2019-12-25 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
US8846054B2 (en) | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
EP2618841B1 (en) | 2010-09-21 | 2016-10-19 | Intervet International B.V. | Bvdv vaccine |
JP6589159B2 (ja) * | 2014-04-01 | 2019-10-16 | 共立製薬株式会社 | 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法 |
CN106456741B (zh) * | 2014-05-23 | 2020-07-21 | 勃林格殷格翰动物保健有限公司 | 包含e2蛋白tav表位中的取代的重组经典猪瘟病毒(csfv) |
CN105779499B (zh) * | 2016-03-23 | 2019-11-19 | 江苏科技大学 | 重组杆状病毒和其应用及构建该重组杆状病毒的载体 |
CN107823639B (zh) * | 2017-11-10 | 2020-10-02 | 齐鲁动物保健品有限公司 | 牛病毒性腹泻病毒灭活疫苗及其制备方法 |
CN108707190B (zh) * | 2018-04-18 | 2021-07-13 | 中国科学院武汉病毒研究所 | 猪瘟病毒ns5b蛋白保真度突变体及其应用 |
CN114853912B (zh) * | 2022-05-24 | 2023-06-13 | 中国农业科学院兰州兽医研究所 | 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用 |
CN115960847B (zh) * | 2023-01-11 | 2024-06-14 | 青岛大学 | 小分子依赖的内含肽自剪接***在制备减毒活疫苗中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6168942B1 (en) * | 1998-11-10 | 2001-01-02 | Pfizer Inc. | Attenuated forms of bovine viral diarrhea virus |
EP1104676A1 (en) * | 1999-11-30 | 2001-06-06 | Boehringer Ingelheim Vetmedica Gmbh | Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
CA2363493C (en) * | 2000-11-22 | 2006-06-06 | Xuemei Cao | Attenuated forms of bovine viral diarrhea virus |
DE10143813A1 (de) * | 2001-09-06 | 2003-04-10 | Boehringer Ingelheim Vetmed | Infektiöser Rindervirusdiarrhoe-Virusklon |
-
2004
- 2004-05-19 DE DE102004025452A patent/DE102004025452A1/de not_active Withdrawn
-
2005
- 2005-05-18 AT AT05741681T patent/ATE420949T1/de active
- 2005-05-18 MX MXPA06013298A patent/MXPA06013298A/es active IP Right Grant
- 2005-05-18 AR ARP050102032A patent/AR049176A1/es active Pending
- 2005-05-18 UY UY28905A patent/UY28905A1/es active IP Right Grant
- 2005-05-18 KR KR1020067026800A patent/KR100908798B1/ko active IP Right Grant
- 2005-05-18 CN CN201310269097.1A patent/CN103352030B/zh active Active
- 2005-05-18 NZ NZ552088A patent/NZ552088A/en unknown
- 2005-05-18 EP EP05741681.0A patent/EP1751276B9/en active Active
- 2005-05-18 PT PT05741681T patent/PT1751276E/pt unknown
- 2005-05-18 RS RS20090106A patent/RS50753B9/sr unknown
- 2005-05-18 AU AU2005243488A patent/AU2005243488B2/en active Active
- 2005-05-18 ES ES05741681T patent/ES2321210T3/es active Active
- 2005-05-18 CN CN200580024345XA patent/CN1989240B/zh active Active
- 2005-05-18 WO PCT/EP2005/005377 patent/WO2005111201A1/en active Application Filing
- 2005-05-18 CA CA2561719A patent/CA2561719C/en active Active
- 2005-05-18 BR BRPI0510396-7A patent/BRPI0510396B1/pt active IP Right Grant
- 2005-05-18 DK DK05741681.0T patent/DK1751276T5/da active
- 2005-05-18 SI SI200530619T patent/SI1751276T1/sl unknown
- 2005-05-18 PL PL05741681T patent/PL1751276T3/pl unknown
- 2005-05-18 JP JP2007517077A patent/JP5006782B2/ja active Active
- 2005-05-18 DE DE602005012381T patent/DE602005012381D1/de active Active
- 2005-05-18 ME MEP-2009-56A patent/ME01119B/me unknown
-
2009
- 2009-04-10 CY CY20091100429T patent/CY1109036T1/el unknown
-
2011
- 2011-11-11 JP JP2011247652A patent/JP5562316B2/ja active Active
-
2015
- 2015-06-16 NL NL300745C patent/NL300745I1/nl unknown
- 2015-06-16 NL NL300744C patent/NL300744I1/nl unknown
- 2015-06-16 NL NL300743C patent/NL300743I1/nl unknown
- 2015-06-19 CY CY2015022C patent/CY2015022I2/el unknown
- 2015-06-19 LU LU92749C patent/LU92749I2/xx unknown
- 2015-06-19 HU HUS1500033C patent/HUS1500033I1/hu unknown
- 2015-06-19 LU LU92748C patent/LU92748I2/xx unknown
- 2015-06-19 CY CY2015021C patent/CY2015021I2/el unknown
- 2015-06-19 LU LU92747C patent/LU92747I2/xx unknown
- 2015-06-19 HU HUS1500031 patent/HUS1500031I1/hu unknown
- 2015-06-19 CY CY2015023C patent/CY2015023I2/el unknown
-
2016
- 2016-04-28 AR ARP160101219A patent/AR104448A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049176A1 (es) | Vacuna que comprende un pestivirus atenuado | |
NO20070551L (no) | Vaksinesammensetninger og fremgangsmater for behandling av koronavirus infeksjon. | |
NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
IL202978A0 (en) | West nile virus vaccine | |
NO20052136L (no) | Vaksine mot Hepatitt C-virus (HCV). | |
MX2023000411A (es) | Vacuna combinada de sars-cov-2 e influenza. | |
AR072302A1 (es) | Pestivirus atenuados. composicion inmunogenica. metodo. | |
NO20061911L (no) | Immunogene sammensetninger | |
EA200701669A1 (ru) | Композиции и способы лечения или предотвращения инфекций, вызванных вирусами семейства flaviviridae | |
WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
AU2002360592A8 (en) | Inhibitors of hepatitis c virus | |
BRPI0415883A (pt) | compostos e composições de nucleosìdeo para o tratamento de infecções virais | |
TW200633995A (en) | Andrographolide derivatives to treat viral infections | |
AR044696A1 (es) | Composicion de vacunas | |
ECSP066805A (es) | Compuestos silinano como inhibidores de cisteína proteasa | |
ATE547118T1 (de) | Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung | |
UY27798A1 (es) | Inhibidores de la arn polimerasa dependiente de arn del virus de la hepatits c y composiciones y tratamientos que los usan. | |
DE602006014720D1 (de) | Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c | |
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
BRPI0516314A (pt) | uso de hiv inteiro e método de tratamento de um indivìduo cronicamente infectado com hiv | |
ATE420658T1 (de) | Imidazoquinolinamine als adjuvantien für hiv dna vakzine | |
CU23496A1 (es) | Composición vacunal contra el virus de la hepatitis c | |
AR109291A1 (es) | Clon de adnc del virus del síndrome reproductivo y respiratorio porcino y usos del mismo | |
TH91790B (th) | วัคซีนรวม ซึ่งประกอบด้วย ไวรัสก่อการท้องเสียของสัตว์จำพวกวัว ที่ถูกทำให้อ่อนกำลังลง | |
TH103175B (th) | วัคซีนซึ่งประกอบรวมด้วยเพสทิไวรัสที่ได้รับการทำให้อ่อนฤทธิ์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |